Cdk8/19 inhibitors for the treatment of cytokine storm
AssigneesUniversity of South Carolina, Senex Biotechnology, Inc.
InventorsIgor B. RONINSON, Eugenia V. BROUDE, Mengqian CHEN
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods for treating a subject comprising the administration of an effective amount of an inhibitor of CDK8 and CDK19 to a subject in need of a treatment for a cytokine storm or elevated amounts of a multiplicity of different cytokine-storm mediating cytokines.
Claims40
A method for treating a subject in need of a treatment for a cytokine storm or elevated amounts of a multiplicity of different cytokine-storm mediating cytokines, the method comprising administering an effective amount of an inhibitor of CDK8 and CDK 19 or a pharmaceutical composition comprising the effective amount of the inhibitor of CDK8 and CDK19 to the subject.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.